http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2159101-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2832c7d78fbba86f80e6fce829974f97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70b8953cfc6c6753183745cd82e24a1a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K6-898 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-24 |
| filingDate | 1999-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2000-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39a6f900e05d8d8ac9a200a6f1db82c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c860a9e52f26c1d0ad70a10bc44d1cfd |
| publicationDate | 2000-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2159101-C1 |
| titleOfInvention | Method for treating periodontium diseases |
| abstract | FIELD: medicine. SUBSTANCE: method involves setting subgingival and subperiosteal implant of osteotropic membrane based on collagen and drug like glucosamine glycans. The osteotropic membrane additionally has bone powder. Membrane is used with 0.1-1.0 mm thickness under the following proportions of ingredients: collagen, glucosamine glycans and the powder are taken in 100: (1- 5): (50-90) proportion, respectively. EFFECT: complex pathogenetic action upon pathologic processes; high anti-inflammatory and hemostatic effectiveness. 2 cl |
| priorityDate | 1999-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.